RegenETP Inc. (RGTPQ)
OTCMKTS: RGTPQ · Delayed Price · USD
0.185
-0.031 (-14.26%)
Jul 24, 2024, 4:00 PM EDT - Market closed
RegenETP Revenue
RegenETP had revenue of $73.00K in the twelve months ending March 31, 2023, down -98.66% year-over-year. In the year 2022, RegenETP had annual revenue of $814.00K, down -91.34%.
Revenue (ttm)
$73.00K
Revenue Growth
-98.66%
P/S Ratio
1.99
Revenue / Employee
$18,500
Employees
44
Market Cap
1.62M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | 814.00K | -8.59M | -91.34% |
| Dec 31, 2021 | 9.40M | -722.00K | -7.13% |
| Dec 31, 2020 | 10.13M | 4.47M | 79.16% |
| Dec 31, 2019 | 5.65M | 1.61M | 39.97% |
| Dec 31, 2018 | 4.04M | 2.48M | 158.35% |
| Oct 31, 2018 | Pro | Pro | Pro |
| Oct 31, 2017 | Pro | Pro | Pro |
| Oct 31, 2016 | Pro | Pro | Pro |
| Oct 31, 2015 | Pro | Pro | Pro |
| Oct 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 379.49B |
| Johnson & Johnson | 78.71B |
| Merck & Co. | 61.40B |
| AbbVie | 54.40B |
| AstraZeneca | 49.13B |
| Novartis AG | 48.86B |
| Thermo Fisher | 42.49B |
| Abbott Laboratories | 40.33B |
RGTPQ News
- 1 year ago - PolarityTE Announces Entry Into a Letter of Intent For Acquisition of the Company - PRNewsWire
- 1 year ago - PolarityTE Reports Third Quarter 2022 Financial Results and Provides Business Update - PRNewsWire
- 1 year ago - PolarityTE Confirms Receipt of Unsolicited, Non-Binding Offer to Acquire the Company - PRNewsWire
- 2 years ago - PolarityTE to Present at the H.C. Wainwright 24th Annual Global Investment Conference on September 14, 2022 - PRNewsWire
- 2 years ago - PolarityTE Announces Resignation of Jeff Dyer from its Board of Directors - PRNewsWire
- 2 years ago - PolarityTE Reports Second Quarter 2022 Financial Results and Provides Business Update - PRNewsWire
- 2 years ago - PolarityTE to Report Q2 2022 Financial Results on August 11, 2022 - PRNewsWire
- 2 years ago - PolarityTE Announces $8.0 Million Registered Direct and Private Placement Offerings Priced At-The-Market Under Nasdaq Rules - PRNewsWire